Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Toxicity: Standard Handling (A)

Native apolipoprotein C-III from human plasma. Major protein of VLDL and chylomicrons. Involved in the uptake of triglycerides by cells. May inhibit the activation of lipoprotein lipase by Apo C-II. Present in normal plasma at 80-150 µg/ml.

Bonnet, E., et al. 2001. J. Clin. Endocrinol. Metab.86, 296.
Hasse, R., et al. 1998. Electrophoresis 9, 569.
Catapano, A.L., et al. 1978. J. Lipid Res. 19, 1047.

Please refer to vial label for lot-specific concentration.

In 10 mM NH₄HCO₃, pH 7.4.

Following initial thaw, aliquot and freeze (-20°C).

Prepared from plasma that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany